Go Pro

Phreesia (PHR) Financials

Phreesia logo
$10.34 +0.17 (+1.64%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$10.30 -0.03 (-0.31%)
As of 09/11/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Phreesia

Annual Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-38 -45 -91 -27 -118 -176 -137 -59 2.31
Consolidated Net Income / (Loss)
-18 -15 -20 -27 -118 -176 -137 -59 2.31
Net Income / (Loss) Continuing Operations
-18 -15 -20 -27 -118 -176 -137 -59 2.31
Total Pre-Tax Income
-18 -15 -22 -27 -118 -176 -135 -56 -8.94
Total Operating Income
-15 -9.49 -15 -26 -117 -177 -136 -58 -6.61
Total Gross Profit
50 63 80 96 132 172 295 354 409
Total Revenue
80 100 125 149 213 281 356 420 481
Operating Revenue
80 100 125 149 213 281 356 420 481
Total Cost of Revenue
30 37 45 52 81 109 61 66 71
Operating Cost of Revenue
30 37 45 52 81 109 61 66 71
Total Operating Expenses
65 72 95 122 249 348 432 412 416
Selling, General & Admin Expense
19 20 30 40 69 80 80 77 80
Marketing Expense
25 26 32 43 106 151 147 121 100
Research & Development Expense
11 14 19 23 52 91 112 117 121
Depreciation Expense
6.83 7.55 8.75 9.77 15 18 18 14 13
Amortization Expense
2.81 4.04 5.17 6.14 6.32 7.32 12 14 18
Other Operating Expenses / (Income)
- - - - - - 63 69 83
Total Other Income / (Expense), net
-3.64 -5.57 -6.78 -1.57 -1.16 0.89 1.14 2.29 -2.33
Interest Expense
3.64 3.50 2.45 1.57 1.08 0.00 2.97 2.35 7.45
Interest & Investment Income
- - - - - 1.06 4.07 2.68 2.17
Other Income / (Expense), net
0.00 -2.07 -4.33 0.00 -0.08 -0.18 0.04 1.96 2.95
Income Tax Expense
0.00 0.00 -1.78 0.05 0.18 0.48 1.54 2.72 -11
Basic Earnings per Share
($24.81) ($24.53) ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Weighted Average Basic Shares Outstanding
1.54M 1.84M 20.30M 39.52M 49.89M 52.44M 54.56M 57.59M 59.74M
Diluted Earnings per Share
($24.81) ($24.53) ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Weighted Average Diluted Shares Outstanding
1.54M 1.84M 20.30M 39.52M 49.89M 52.44M 54.56M 57.59M 61.49M
Weighted Average Basic & Diluted Shares Outstanding
1.54M 1.84M 20.30M 39.52M 51.95M 53.36M 56.39M 58.77M 60.76M

Quarterly Income Statements for Phreesia

This table shows Phreesia's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Consolidated Net Income / (Loss)
-31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Net Income / (Loss) Continuing Operations
-31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Total Pre-Tax Income
-30 -19 -17 -14 -5.38 -3.18 -0.56 5.13 -10 4.72 3.24
Total Operating Income
-30 -19 -17 -14 -7.61 -3.29 -1.51 3.74 -5.56 6.75 7.61
Total Gross Profit
63 67 69 72 76 99 100 82 169 113 110
Total Revenue
95 101 102 107 110 116 117 120 127 131 129
Operating Revenue
95 101 102 107 110 116 117 120 127 131 129
Total Cost of Revenue
32 34 33 35 34 17 17 38 -42 18 19
Operating Cost of Revenue
32 34 33 35 34 17 17 38 -42 18 19
Total Operating Expenses
93 87 87 86 84 103 101 79 175 107 103
Selling, General & Admin Expense
19 19 19 20 18 16 19 17 27 18 17
Marketing Expense
36 32 30 30 29 26 25 24 25 24 25
Research & Development Expense
30 29 30 29 30 32 29 29 31 28 28
Depreciation Expense
4.35 3.52 3.92 3.57 3.17 2.99 3.28 3.20 3.51 3.37 3.34
Amortization Expense
3.90 3.15 3.38 3.52 3.65 3.89 4.13 4.28 6.18 6.58 6.66
Other Operating Expenses / (Income)
- - - - - 21 20 - - 26 24
Total Other Income / (Expense), net
-0.85 0.21 -0.04 -0.12 2.24 0.11 0.94 1.39 -4.77 -2.03 -4.37
Interest Expense
- - - - - 0.44 0.39 - - 2.32 1.73
Interest & Investment Income
0.18 0.24 0.05 0.03 0.02 0.21 1.00 0.38 1.42 0.30 0.25
Other Income / (Expense), net
0.08 -0.03 -0.09 -0.14 2.22 0.34 0.34 1.01 1.27 -0.01 -2.89
Income Tax Expense
0.22 0.51 0.75 0.44 1.01 0.74 -1.22 0.85 -12 1.76 1.32
Basic Earnings per Share
($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Weighted Average Basic Shares Outstanding
54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 59.59M 60.01M 59.74M 60.94M 61.88M
Diluted Earnings per Share
($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Weighted Average Diluted Shares Outstanding
54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 61.69M 61.56M 61.49M 62.04M 62.46M
Weighted Average Basic & Diluted Shares Outstanding
56.39M 57.40M 57.77M 58.12M 58.77M 59.50M 59.91M 60.29M 60.76M 61.81M 62.07M

Annual Cash Flow Statements for Phreesia

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Net Change in Cash & Equivalents
8.18 -8.96 89 128 95 -137 -89 -3.30 -10
Net Cash From Operating Activities
-11 -2.13 0.83 2.89 -75 -90 -32 32 79
Net Cash From Continuing Operating Activities
-11 -2.13 0.83 2.89 -75 -90 -32 32 79
Net Income / (Loss) Continuing Operations
-18 -15 -20 -27 -118 -176 -137 -59 2.31
Consolidated Net Income / (Loss)
-18 -15 -20 -27 -118 -176 -137 -59 2.31
Depreciation Expense
9.64 12 14 16 21 25 29 28 31
Amortization Expense
2.29 2.44 2.42 2.41 2.50 2.01 1.38 2.05 3.55
Non-Cash Adjustments To Reconcile Net Income
-0.37 1.59 11 16 38 62 75 67 65
Changes in Operating Assets and Liabilities, net
-4.51 -2.69 -6.53 -4.16 -18 -3.43 -1.41 -6.28 -23
Net Cash From Investing Activities
-12 -11 -12 -25 -65 -26 -40 -24 -162
Net Cash From Continuing Investing Activities
-12 -11 -12 -25 -65 -26 -40 -24 -162
Purchase of Property, Plant & Equipment
-12 -9.83 -12 -19 -31 -26 -25 -24 -24
Acquisitions
0.00 -1.19 - -6.51 -34 0.00 -15 0.00 -153
Other Investing Activities, net
- - - - - - 0.00 0.00 16
Net Cash From Financing Activities
31 4.19 100 151 235 -21 -17 -11 73
Net Cash From Continuing Financing Activities
31 4.19 100 151 235 -21 -17 -11 73
Repayment of Debt
-24 -8.30 -39 -23 -1.16 -0.61 -2.68 -1.35 -34
Issuance of Debt
22 15 30 - 0.00 0.00 1.69 0.00 110
Issuance of Common Equity
0.00 0.00 131 175 248 3.32 3.21 2.92 2.37
Other Financing Activities, net
0.15 -2.11 -0.09 -1.20 -12 -24 -19 -13 -5.37
Effect of Exchange Rate Changes
- - - - - 0.00 0.00 -0.11 -0.18
Cash Interest Paid
2.80 2.80 2.31 1.47 0.80 0.76 1.31 2.19 1.61
Cash Income Taxes Paid
- 0.00 0.00 0.06 0.05 0.04 0.04 3.07 1.90

Quarterly Cash Flow Statements for Phreesia

This table details how cash moves in and out of Phreesia's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
Net Change in Cash & Equivalents
-16 -7.99 2.27 -0.06 2.48 6.65 7.40 8.11 -33 2.57 -1.76
Net Cash From Operating Activities
-3.08 -0.72 11 5.79 16 15 15 15 34 24 18
Net Cash From Continuing Operating Activities
-3.08 -0.72 11 5.79 16 15 15 15 34 24 18
Net Income / (Loss) Continuing Operations
-31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Consolidated Net Income / (Loss)
-31 -20 -18 -14 -6.39 -3.91 0.65 4.27 1.30 2.96 1.92
Depreciation Expense
8.25 6.67 7.30 7.09 6.82 6.88 7.41 7.48 9.69 9.95 10.00
Amortization Expense
0.27 0.25 0.24 1.38 0.17 0.17 0.30 0.17 2.90 0.55 0.24
Non-Cash Adjustments To Reconcile Net Income
20 17 17 18 16 18 17 16 14 17 8.01
Changes in Operating Assets and Liabilities, net
-0.54 -5.28 4.98 -6.01 0.03 -6.16 -10 -13 5.71 -6.19 -1.84
Net Cash From Investing Activities
-8.16 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67 -143 4.80 22
Net Cash From Continuing Investing Activities
-8.16 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67 -143 4.80 22
Purchase of Property, Plant & Equipment
-7.86 -5.45 -7.40 -4.18 -7.06 -7.39 -5.20 -6.67 -5.14 -7.55 -4.50
Other Investing Activities, net
- - - - - 0.00 - - - 12 27
Net Cash From Financing Activities
-4.61 -1.83 -1.38 -1.65 -6.63 -0.84 -2.15 -0.67 77 -26 -42
Net Cash From Continuing Financing Activities
-4.61 -1.83 -1.38 -1.65 -6.63 -0.84 -2.15 -0.67 77 -26 -42
Repayment of Debt
-2.11 -0.44 -0.30 -0.30 -0.31 -0.36 -0.33 -0.35 -33 -116 -41
Issuance of Common Equity
0.43 0.91 0.69 0.84 0.48 0.77 0.58 0.63 0.40 0.52 0.24
Other Financing Activities, net
-2.93 -2.30 -1.78 -2.19 -6.79 -1.25 -2.40 -0.95 -0.78 -2.64 -1.19
Effect of Exchange Rate Changes
- -0.00 -0.01 -0.01 -0.09 0.03 -0.09 -0.03 -0.09 -0.06 0.03
Cash Interest Paid
0.66 0.48 0.38 0.60 0.74 0.32 0.33 0.24 0.72 3.85 0.70
Cash Income Taxes Paid
-0.01 1.59 0.42 0.55 0.51 0.55 0.76 0.33 0.25 1.18 2.88

Annual Balance Sheets for Phreesia

This table presents Phreesia's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
Total Assets
59 159 327 494 370 370 388 664
Total Current Assets
33 132 272 386 262 196 203 280
Restricted Cash
- - - - - - - 74
Accounts Receivable
16 22 29 40 51 65 74 97
Prepaid Expenses
3.81 5.16 7.25 11 11 14 16 18
Other Current Assets
12 14 17 21 24 29 30 91
Plant, Property, & Equipment, net
14 14 0.00 0.00 22 17 24 0.00
Total Noncurrent Assets
12 13 54 108 86 158 161 384
Noncurrent Note & Lease Receivables
- - - - - - - 53
Goodwill
0.25 0.25 8.31 34 34 76 76 170
Intangible Assets
9.25 9.93 13 30 47 78 81 134
Noncurrent Deferred & Refundable Income Taxes
0.00 0.78 0.66 0.52 0.08 - 0.00 1.59
Other Noncurrent Operating Assets
2.23 1.77 32 44 5.58 4.13 4.73 25
Total Liabilities & Shareholders' Equity
59 159 327 494 370 370 388 664
Total Liabilities
64 57 63 77 82 119 124 327
Total Current Liabilities
28 35 55 68 79 110 114 183
Short-Term Debt
1.97 2.32 4.86 5.82 5.17 6.06 8.04 7.97
Accounts Payable
3.75 6.02 4.39 5.12 11 8.48 5.62 11
Accrued Expenses
5.51 9.24 18 20 22 37 37 41
Current Deferred Revenue
6.49 5.40 11 16 18 24 33 50
Other Current Liabilities
10 12 17 21 24 34 30 73
Total Noncurrent Liabilities
36 22 8.37 8.76 3.20 8.76 9.58 143
Long-Term Debt
28 22 6.47 7.42 2.73 5.40 8.15 92
Noncurrent Deferred Revenue
- - - 0.07 0.13 0.10 0.12 0.24
Noncurrent Deferred & Payable Income Tax Liabilities
- - - - 0.00 0.27 0.48 4.50
Other Noncurrent Operating Liabilities
5.50 0.00 1.90 1.28 0.35 2.99 0.83 46
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-211 102 263 417 288 251 265 337
Total Preferred & Common Equity
-211 102 263 417 288 251 265 337
Preferred Stock
- - - - 0.00 0.00 0.00 0.00
Total Common Equity
-211 102 263 417 288 251 265 337
Common Stock
0.02 387 580 861 927 1,040 1,112 1,182
Retained Earnings
-211 -284 -312 -430 -606 -743 -801 -799
Treasury Stock
0.00 -0.40 -4.97 -14 -34 -46 -46 -46
Accumulated Other Comprehensive Income / (Loss)
- - - - - 0.00 -0.05 -0.38

Quarterly Balance Sheets for Phreesia

This table presents Phreesia's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 4/30/2023 7/31/2023 10/31/2023 4/30/2024 7/31/2024 10/31/2024 4/30/2025 7/31/2025 10/31/2025 4/30/2026 7/31/2026
Total Assets
354 340 375 372 362 376 400 409 423 666 647
Total Current Assets
240 219 199 191 181 190 215 223 241 267 254
Restricted Cash
- - - - - - - - - 75 73
Accounts Receivable
53 54 57 66 61 71 75 77 88 90 89
Prepaid Expenses
10 12 14 14 12 11 16 18 20 16 19
Other Current Assets
27 26 25 31 26 25 33 29 26 87 72
Plant, Property, & Equipment, net
0.00 0.00 20 22 21 26 23 23 21 0.00 0.00
Total Noncurrent Assets
114 121 156 159 160 160 161 163 161 399 393
Noncurrent Note & Lease Receivables
- - - - - - - - - 66 66
Goodwill
34 41 75 76 76 76 76 76 76 170 171
Intangible Assets
49 54 77 79 80 80 81 80 80 132 75
Noncurrent Deferred & Refundable Income Taxes
0.00 0.00 0.00 - - - - 1.64 1.64 1.59 0.99
Other Noncurrent Operating Assets
31 26 3.28 4.23 4.86 3.98 4.85 5.45 4.35 30 80
Total Liabilities & Shareholders' Equity
354 340 375 372 362 376 400 409 423 666 647
Total Liabilities
90 93 110 119 111 121 118 111 103 307 275
Total Current Liabilities
83 85 98 108 102 109 111 105 99 152 144
Short-Term Debt
6.98 7.11 6.75 7.75 7.16 8.87 8.35 7.10 6.20 5.30 5.28
Accounts Payable
7.60 7.95 11 6.68 6.98 16 3.20 6.53 6.22 12 12
Accrued Expenses
23 28 28 33 33 29 34 35 31 31 36
Current Deferred Revenue
18 16 22 24 21 22 31 27 30 40 33
Other Current Liabilities
27 26 30 37 34 33 34 30 26 65 58
Total Noncurrent Liabilities
7.26 8.55 12 11 8.90 12 7.49 5.51 4.36 155 131
Long-Term Debt
6.69 8.06 6.85 8.69 7.30 10 6.16 4.58 3.35 85 61
Noncurrent Deferred Revenue
0.18 0.10 0.10 0.08 0.06 0.20 0.11 0.08 0.15 3.22 4.69
Noncurrent Deferred & Payable Income Tax Liabilities
0.14 0.18 0.22 0.33 0.39 0.45 0.57 0.63 0.68 4.62 4.59
Other Noncurrent Operating Liabilities
0.26 0.22 4.46 1.96 1.15 0.97 0.65 0.22 0.17 62 61
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
264 247 265 253 251 255 282 298 320 359 372
Total Preferred & Common Equity
264 247 265 253 251 255 282 298 320 359 372
Preferred Stock
- - - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
264 247 265 253 251 255 282 298 320 359 372
Common Stock
948 972 1,022 1,061 1,078 1,095 1,133 1,148 1,167 1,203 1,213
Retained Earnings
-644 -680 -712 -763 -781 -795 -805 -805 -800 -796 -794
Treasury Stock
-41 -44 -46 -46 -46 -46 -46 -46 -46 -47 -47
Accumulated Other Comprehensive Income / (Loss)
- - - 0.00 -0.00 -0.01 0.38 0.11 -0.36 -0.57 -0.62

Annual Metrics And Ratios for Phreesia

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/31/2018 1/31/2019 1/31/2020 1/31/2021 1/31/2022 1/31/2023 1/31/2024 1/31/2025 1/31/2026
DEI Shares Outstanding
- - - - - - - - 60,287,003.00
DEI Adjusted Shares Outstanding
- - - - - - - - 60,287,003.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.04
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 25.12% 24.92% 19.15% 43.42% 31.74% 26.84% 17.83% 14.48%
EBITDA Growth
0.00% 194.53% -232.71% -123.89% -1,166.93% -60.50% 29.34% 75.18% 219.60%
EBIT Growth
0.00% 20.55% -69.81% -30.78% -355.38% -51.18% 22.80% 58.85% 93.48%
NOPAT Growth
0.00% 34.76% -61.13% -67.81% -355.05% -51.14% 22.70% 57.43% 88.62%
Net Income Growth
0.00% 17.21% -34.73% -34.49% -332.95% -49.07% 22.29% 57.24% 103.94%
EPS Growth
0.00% 1.13% 81.66% 84.67% -243.48% -41.77% 25.30% 59.36% 103.92%
Operating Cash Flow Growth
0.00% 80.88% 138.78% 249.88% -2,685.12% -20.63% 64.07% 200.01% 143.40%
Free Cash Flow Firm Growth
0.00% 0.00% 39.63% -93.40% -271.26% 11.72% -20.63% 59.14% -176.03%
Invested Capital Growth
0.00% 0.00% 34.86% 57.73% 108.94% 1.99% 47.34% 12.20% 84.71%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 6.44% 8.23% 7.08% 5.45% 3.62% 3.75%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -78.48% -63.51% 4.92% 9.77% 46.28% 27.21%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -13.72% -49.12% 3.69% 7.01% 30.03% 23.29%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -16.36% -48.85% 3.71% 6.98% 27.44% 23.71%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -19.37% -48.06% 4.57% 5.11% 29.30% 142.87%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 6.15% 6.34% 30.14% 140.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 119.45% 3,221.84% -128.79% 19.68% 28.37% 148.19% 28.34%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -84.09% 30.48% 3.58% 15.24% -356.02%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 24.91% 73.54% -0.81% 0.32% 2.48% 62.62%
Profitability Metrics
- - - - - - - - -
Gross Margin
62.71% 62.96% 64.16% 64.77% 61.83% 61.10% 65.19% 67.86% 85.15%
EBITDA Margin
-3.28% 2.48% -2.63% -4.94% -43.66% -53.19% -29.63% -6.24% 6.52%
Operating Margin
-18.23% -9.50% -12.26% -17.27% -54.78% -62.85% -38.30% -13.84% -1.38%
EBIT Margin
-18.22% -11.57% -15.73% -17.27% -54.82% -62.91% -38.29% -13.37% -0.76%
Profit (Net Income) Margin
-22.79% -15.08% -16.26% -18.36% -55.41% -62.71% -38.42% -13.94% 0.48%
Tax Burden Percent
100.00% 100.00% 91.94% 100.18% 100.15% 100.28% 101.14% 104.87% -25.79%
Interest Burden Percent
125.04% 130.31% 112.46% 106.13% 100.93% 99.40% 99.20% 99.41% 244.33%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% -50.62% -34.73% -39.38% -94.77% -104.85% -64.90% -21.85% -1.65%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -105.37% 18.96% -32.57% -80.44% -82.45% -31.12% 2.93% -34.86%
Return on Net Nonoperating Assets (RNNOA)
0.00% 722.43% -6.95% 24.43% 60.05% 54.88% 14.13% -0.82% 2.42%
Return on Equity (ROE)
0.00% 671.81% -41.68% -14.95% -34.72% -49.96% -50.77% -22.67% 0.77%
Cash Return on Invested Capital (CROIC)
0.00% -250.62% -64.42% -84.18% -165.29% -106.82% -103.18% -33.35% -61.16%
Operating Return on Assets (OROA)
0.00% -19.50% -18.01% -10.58% -28.47% -40.88% -36.86% -14.80% -0.70%
Return on Assets (ROA)
0.00% -25.42% -18.62% -11.24% -28.78% -40.75% -36.98% -15.43% 0.44%
Return on Common Equity (ROCE)
0.00% 31,608.97% 46.70% -14.95% -34.72% -49.96% -50.77% -22.67% 0.77%
Return on Equity Simple (ROE_SIMPLE)
0.00% 7.14% -19.92% -10.37% -28.32% -61.20% -54.44% -22.10% 0.00%
Net Operating Profit after Tax (NOPAT)
-10 -6.65 -11 -18 -82 -124 -96 -41 -4.63
NOPAT Margin
-12.76% -6.65% -8.58% -12.09% -38.35% -44.00% -26.81% -9.69% -0.96%
Net Nonoperating Expense Percent (NNEP)
0.00% 54.75% -53.68% -6.81% -14.33% -22.40% -33.78% -24.79% 33.20%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - -41.79% -36.34% -14.47% -1.06%
Cost of Revenue to Revenue
37.29% 37.04% 35.84% 35.23% 38.17% 38.90% 34.81% 32.14% 14.85%
SG&A Expenses to Revenue
23.60% 20.10% 24.41% 27.21% 32.21% 28.62% 22.43% 18.25% 16.63%
R&D to Revenue
14.25% 14.36% 14.92% 15.22% 24.51% 32.48% 31.53% 27.96% 25.28%
Operating Expenses to Revenue
80.94% 72.47% 76.42% 82.03% 116.62% 123.95% 103.50% 81.70% 86.53%
Earnings before Interest and Taxes (EBIT)
-15 -12 -20 -26 -117 -177 -136 -56 -3.66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-2.62 2.47 -3.28 -7.35 -93 -149 -106 -26 31
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 10.92 10.95 3.83 6.87 5.64 6.25 2.40
Price to Tangible Book Value (P/TBV)
0.00 0.00 12.13 11.92 4.52 9.53 14.49 15.31 24.45
Price to Revenue (P/Rev)
2.09 1.67 8.91 19.39 7.50 7.04 3.98 3.94 1.68
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 351.11
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.28%
Enterprise Value to Invested Capital (EV/IC)
0.00 15.40 29.54 47.90 11.12 15.20 7.65 8.06 2.30
Enterprise Value to Revenue (EV/Rev)
0.00 4.05 8.38 18.00 6.09 6.44 3.77 3.78 1.74
Enterprise Value to EBITDA (EV/EBITDA)
0.00 163.53 0.00 0.00 0.00 0.00 0.00 0.00 26.67
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 1,266.33 925.93 0.00 0.00 0.00 48.99 10.61
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 -7.20 0.23 0.04 0.03 0.03 0.05 0.06 0.30
Long-Term Debt to Equity
0.00 -6.76 0.21 0.02 0.02 0.01 0.02 0.03 0.27
Financial Leverage
0.00 -6.86 -0.37 -0.75 -0.75 -0.67 -0.45 -0.28 -0.07
Leverage Ratio
0.00 -13.22 2.24 1.33 1.21 1.23 1.37 1.47 1.75
Compound Leverage Factor
0.00 -17.22 2.52 1.41 1.22 1.22 1.36 1.46 4.27
Debt to Total Capital
0.00% 116.13% 18.98% 4.13% 3.08% 2.67% 4.36% 5.76% 22.89%
Short-Term Debt to Total Capital
0.00% 7.07% 1.85% 1.77% 1.35% 1.75% 2.30% 2.86% 1.82%
Long-Term Debt to Total Capital
0.00% 109.06% 17.13% 2.36% 1.72% 0.92% 2.05% 2.90% 21.07%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 742.74% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% -758.87% 81.02% 95.87% 96.92% 97.33% 95.64% 94.24% 77.11%
Debt to EBITDA
0.00 13.06 -7.27 -1.54 -0.14 -0.05 -0.11 -0.62 3.19
Net Debt to EBITDA
0.00 12.43 20.25 28.23 3.23 1.13 0.72 2.60 0.84
Long-Term Debt to EBITDA
0.00 12.26 -6.56 -0.88 -0.08 -0.02 -0.05 -0.31 2.94
Debt to NOPAT
0.00 -4.86 -2.23 -0.63 -0.16 -0.06 -0.12 -0.40 -21.62
Net Debt to NOPAT
0.00 -4.63 6.21 11.54 3.68 1.37 0.80 1.67 -5.67
Long-Term Debt to NOPAT
0.00 -4.56 -2.01 -0.36 -0.09 -0.02 -0.06 -0.20 -19.90
Altman Z-Score
0.00 -2.26 10.33 26.96 11.63 11.91 4.37 6.02 0.68
Noncontrolling Interest Sharing Ratio
0.00% -4,605.04% 212.04% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.19 3.72 4.95 5.65 3.32 1.78 1.78 1.53
Quick Ratio
0.00 0.63 3.18 4.51 5.17 2.89 1.38 1.38 0.53
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -33 -20 -38 -143 -126 -152 -62 -171
Operating Cash Flow to CapEx
-93.12% -21.66% 6.70% 15.56% -242.53% -343.94% -129.01% 134.42% 323.05%
Free Cash Flow to Firm to Interest Expense
0.00 -9.39 -8.12 -24.42 -131.57 0.00 -135.86 0.00 -22.98
Operating Cash Flow to Interest Expense
-3.06 -0.61 0.34 1.84 -68.92 0.00 -28.96 0.00 10.57
Operating Cash Flow Less CapEx to Interest Expense
-6.34 -3.41 -4.70 -9.97 -97.34 0.00 -51.41 0.00 7.30
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 1.69 1.14 0.61 0.52 0.65 0.96 1.11 0.91
Accounts Receivable Turnover
0.00 6.21 6.56 5.83 6.15 6.13 6.13 6.06 5.62
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 7.03 8.70 0.00 0.00 0.00 18.47 20.70 0.00
Accounts Payable Turnover
0.00 9.87 9.16 10.07 17.12 13.70 12.84 19.14 8.35
Days Sales Outstanding (DSO)
0.00 58.73 55.65 62.64 59.32 59.55 59.55 60.20 64.96
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 37.00 39.86 36.25 21.32 26.65 28.43 19.07 43.73
Cash Conversion Cycle (CCC)
0.00 21.74 15.79 26.39 38.00 32.90 31.12 41.13 21.24
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 26 35 56 117 119 175 197 363
Invested Capital Turnover
0.00 7.61 4.05 3.26 2.47 2.38 2.42 2.26 1.72
Increase / (Decrease) in Invested Capital
0.00 26 9.16 20 61 2.32 56 21 167
Enterprise Value (EV)
0.00 404 1,046 2,676 1,298 1,809 1,342 1,586 836
Market Capitalization
167 167 1,112 2,883 1,598 1,977 1,418 1,654 810
Book Value per Share
$0.00 ($114.35) $2.84 $5.96 $8.14 $5.46 $4.52 $4.56 $5.59
Tangible Book Value per Share
$0.00 ($119.50) $2.55 $5.48 $6.89 $3.93 $1.76 $1.86 $0.55
Total Capital
0.00 28 126 275 431 296 263 281 437
Total Debt
0.00 32 24 11 13 7.90 11 16 100
Total Long-Term Debt
0.00 30 22 6.47 7.42 2.73 5.40 8.15 92
Net Debt
0.00 31 -66 -207 -301 -169 -76 -68 26
Capital Expenditures (CapEx)
12 9.83 12 19 31 26 25 24 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 5.81 8.19 3.36 9.93 12 4.10 13 31
Debt-free Net Working Capital (DFNWC)
0.00 7.35 99 222 324 189 92 97 105
Net Working Capital (NWC)
0.00 5.39 96 217 318 183 86 89 97
Net Nonoperating Expense (NNE)
8.00 8.42 9.58 9.32 36 53 41 18 -6.93
Net Nonoperating Obligations (NNO)
0.00 31 -66 -207 -301 -169 -76 -68 26
Total Depreciation and Amortization (D&A)
12 14 16 18 24 27 31 30 35
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 5.82% 6.57% 2.26% 4.66% 4.23% 1.15% 3.12% 6.40%
Debt-free Net Working Capital to Revenue
0.00% 7.36% 78.94% 149.41% 151.82% 67.13% 25.71% 23.18% 21.76%
Net Working Capital to Revenue
0.00% 5.39% 77.08% 146.14% 149.09% 65.29% 24.01% 21.26% 20.10%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 37.52M 44.90M 49.89M 52.44M 54.56M 57.59M 59.74M
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($4.50) ($0.69) ($2.37) ($3.36) ($2.51) ($1.02) $0.04
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 37.52M 44.90M 49.89M 52.44M 54.56M 57.59M 61.49M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 ($4.50) ($0.69) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 20.30M 39.52M 51.95M 53.36M 56.39M 58.77M 60.76M
Normalized Net Operating Profit after Tax (NOPAT)
-10 -6.65 -11 -18 -82 -124 -96 -41 -4.63
Normalized NOPAT Margin
-12.76% -6.65% -8.58% -12.09% -38.35% -44.00% -26.81% -9.69% -0.96%
Pre Tax Income Margin
-22.79% -15.08% -17.69% -18.32% -55.33% -62.53% -37.99% -13.29% -1.86%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
-3.99 -3.30 -8.03 -16.32 -107.84 0.00 -122.03 0.00 -0.49
NOPAT to Interest Expense
-2.80 -1.90 -4.38 -11.42 -75.44 0.00 -85.45 0.00 -0.62
EBIT Less CapEx to Interest Expense
-7.28 -6.11 -13.07 -28.13 -136.25 0.00 -144.48 0.00 -3.76
NOPAT Less CapEx to Interest Expense
-6.08 -4.70 -9.42 -23.23 -103.85 0.00 -107.90 0.00 -3.89
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% -73.70% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -1.29% -104.33% -1.06% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Phreesia

This table displays calculated financial ratios and metrics derived from Phreesia's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 1/31/2024 4/30/2024 7/31/2024 10/31/2024 1/31/2025 4/30/2025 7/31/2025 10/31/2025 1/31/2026 4/30/2026 7/31/2026
DEI Shares Outstanding
- - - - - - - - 60,287,003.00 60,763,065.00 61,811,889.00
DEI Adjusted Shares Outstanding
- - - - - - - - 60,287,003.00 60,763,065.00 61,811,889.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.02 0.05 0.03
Growth Metrics
- - - - - - - - - - -
Revenue Growth
24.05% 20.72% 18.97% 16.57% 15.45% 14.54% 14.83% 12.67% 15.85% 12.94% 10.41%
EBITDA Growth
35.27% 58.97% 67.20% 77.31% 107.62% 132.74% 167.02% 324.71% 419.26% 320.53% 128.60%
EBIT Growth
25.86% 48.74% 53.10% 56.42% 81.71% 84.84% 93.23% 133.92% 20.59% 328.62% 503.07%
NOPAT Growth
25.71% 48.76% 53.40% 56.80% 74.26% 83.07% 91.25% 132.16% 27.00% 284.02% 527.07%
Net Income Growth
19.40% 47.45% 51.01% 54.91% 79.15% 80.15% 103.63% 129.65% 120.27% 175.70% 193.27%
EPS Growth
23.61% 50.00% 54.41% 56.90% 80.00% 80.00% 103.23% 128.00% 127.27% 171.43% 200.00%
Operating Cash Flow Growth
80.64% 94.72% 218.54% 191.68% 628.14% 2,159.64% 34.12% 167.36% 107.07% 61.09% 23.55%
Free Cash Flow Firm Growth
-155.24% -153.12% -46.55% 65.22% 65.32% 75.60% 53.77% -5.63% -538.27% -792.67% -425.27%
Invested Capital Growth
47.34% 48.73% 36.79% 9.83% 12.20% 8.53% 14.89% 16.41% 84.71% 82.19% 72.83%
Revenue Q/Q Growth
3.70% 6.54% 0.89% 4.59% 2.70% 5.70% 1.14% 2.63% 5.60% 3.04% -1.13%
EBITDA Q/Q Growth
13.73% 40.28% 22.06% 43.50% 128.99% 156.47% 59.52% 89.47% -33.01% 107.71% -13.28%
EBIT Q/Q Growth
8.09% 34.05% 11.02% 19.19% 61.43% 45.34% 60.29% 505.21% -190.28% 257.38% -29.99%
NOPAT Q/Q Growth
7.70% 34.34% 11.32% 19.62% 45.01% 56.82% 54.15% 395.38% -224.84% 208.85% 6.40%
Net Income Q/Q Growth
4.05% 35.65% 8.67% 20.04% 55.63% 38.75% 116.71% 553.06% -69.68% 128.80% -35.27%
EPS Q/Q Growth
5.17% 36.36% 11.43% 19.35% 56.00% 36.36% 114.29% 600.00% -57.14% 66.67% -40.00%
Operating Cash Flow Q/Q Growth
51.22% 76.58% 1,634.12% -47.70% 181.00% -8.65% -0.10% 4.26% 117.64% -28.93% -23.38%
Free Cash Flow Firm Q/Q Growth
0.26% 1.72% 18.74% 56.34% 0.54% 30.87% -54.00% 0.24% -500.95% 3.31% 9.38%
Invested Capital Q/Q Growth
0.32% 8.13% -2.98% 4.36% 2.48% 4.60% 2.71% 5.73% 62.62% 3.17% -2.57%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
66.56% 66.39% 67.87% 67.66% 69.40% 67.17% 67.90% 68.40% 133.34% 86.51% 85.11%
EBITDA Margin
-22.08% -12.37% -9.56% -5.16% 1.46% 3.54% 5.58% 10.30% 6.53% 13.17% 11.55%
Operating Margin
-31.13% -19.19% -16.87% -12.96% -6.94% -2.84% -1.29% 3.11% -4.37% 5.15% 5.88%
EBIT Margin
-31.05% -19.22% -16.95% -13.10% -4.92% -2.54% -1.00% 3.94% -3.37% 5.15% 3.65%
Profit (Net Income) Margin
-32.26% -19.48% -17.64% -13.49% -5.83% -3.38% 0.56% 3.55% 1.02% 2.26% 1.48%
Tax Burden Percent
100.71% 102.65% 104.34% 103.17% 118.86% 123.12% -116.16% 83.34% -12.54% 62.74% 59.22%
Interest Burden Percent
103.17% 98.77% 99.73% 99.81% 99.65% 107.80% 48.08% 108.01% 240.97% 70.05% 68.62%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.66% 0.00% 37.26% 40.78%
Return on Invested Capital (ROIC)
-52.75% -31.65% -28.91% -20.04% -10.96% -4.36% -2.05% 5.77% -5.25% 5.52% 6.13%
ROIC Less NNEP Spread (ROIC-NNEP)
-44.63% -25.49% -22.28% -13.85% -9.49% -2.05% -4.27% 4.32% -30.08% 9.72% 11.69%
Return on Net Nonoperating Assets (RNNOA)
20.26% 9.83% 8.04% 4.07% 2.65% 0.53% 1.20% -1.20% 2.09% -0.92% -1.62%
Return on Equity (ROE)
-32.48% -21.81% -20.87% -15.98% -8.31% -3.83% -0.85% 4.57% -3.17% 4.60% 4.50%
Cash Return on Invested Capital (CROIC)
-103.18% -91.27% -74.27% -39.92% -33.35% -23.04% -23.15% -18.08% -61.16% -57.43% -36.95%
Operating Return on Assets (OROA)
-29.88% -19.78% -18.81% -14.14% -5.44% -2.86% -1.17% 4.57% -3.08% 4.79% 3.51%
Return on Assets (ROA)
-31.05% -20.06% -19.58% -14.56% -6.45% -3.80% 0.65% 4.11% 0.93% 2.10% 1.43%
Return on Common Equity (ROCE)
-32.48% -21.81% -20.87% -15.98% -8.31% -3.83% -0.85% 4.57% -3.17% 4.60% 4.50%
Return on Equity Simple (ROE_SIMPLE)
0.00% -47.11% -39.92% -32.52% 0.00% -15.14% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-21 -14 -12 -9.69 -5.33 -2.30 -1.05 3.12 -3.89 4.23 4.51
NOPAT Margin
-21.79% -13.43% -11.81% -9.07% -4.86% -1.98% -0.90% 2.59% -3.06% 3.23% 3.48%
Net Nonoperating Expense Percent (NNEP)
-8.12% -6.15% -6.62% -6.19% -1.47% -2.31% 2.22% 1.45% 24.83% -4.20% -5.56%
Return On Investment Capital (ROIC_SIMPLE)
-7.88% - - - -1.90% -0.78% -0.34% 0.94% -0.89% 0.94% 1.03%
Cost of Revenue to Revenue
33.44% 33.61% 32.13% 32.34% 30.60% 32.83% 32.10% 31.60% -33.34% 13.49% 14.89%
SG&A Expenses to Revenue
19.81% 18.82% 19.09% 18.38% 16.79% 14.15% 16.24% 14.53% 21.22% 14.02% 12.75%
R&D to Revenue
31.43% 28.53% 28.93% 27.45% 27.01% 27.45% 24.97% 24.48% 24.34% 21.64% 21.30%
Operating Expenses to Revenue
97.69% 85.58% 84.73% 80.62% 76.34% 70.00% 69.18% 65.29% 137.72% 81.36% 79.24%
Earnings before Interest and Taxes (EBIT)
-29 -19 -17 -14 -5.40 -2.95 -1.17 4.75 -4.28 6.74 4.72
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-21 -13 -9.76 -5.52 1.60 4.10 6.54 12 8.30 17 15
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.64 4.63 5.70 4.15 6.25 5.20 5.38 4.23 2.40 1.56 1.78
Price to Tangible Book Value (P/TBV)
14.49 11.95 14.94 10.74 15.31 11.69 11.31 8.23 24.45 9.68 5.27
Price to Revenue (P/Rev)
3.98 3.13 3.67 2.61 3.94 3.38 3.57 2.93 1.68 1.13 1.31
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 351.11 60.94 63.49
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.28% 1.64% 1.58%
Enterprise Value to Invested Capital (EV/IC)
7.65 5.83 7.42 5.18 8.06 6.76 7.18 5.64 2.30 1.53 1.80
Enterprise Value to Revenue (EV/Rev)
3.77 2.96 3.50 2.45 3.78 3.20 3.38 2.72 1.74 1.16 1.29
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 225.64 51.13 26.67 12.94 12.42
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 95.41 55.08
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 240.12 13.86
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 1,433.55 76.19 48.99 29.00 29.34 20.51 10.61 6.55 7.19
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.05 0.07 0.06 0.08 0.06 0.05 0.04 0.03 0.30 0.25 0.18
Long-Term Debt to Equity
0.02 0.03 0.03 0.04 0.03 0.02 0.02 0.01 0.27 0.24 0.16
Financial Leverage
-0.45 -0.39 -0.36 -0.29 -0.28 -0.26 -0.28 -0.28 -0.07 -0.09 -0.14
Leverage Ratio
1.37 1.41 1.41 1.45 1.47 1.44 1.40 1.39 1.75 1.66 1.58
Compound Leverage Factor
1.42 1.39 1.41 1.44 1.46 1.56 0.67 1.50 4.21 1.17 1.08
Debt to Total Capital
4.36% 6.11% 5.44% 7.00% 5.76% 4.89% 3.77% 2.90% 22.89% 20.15% 15.16%
Short-Term Debt to Total Capital
2.30% 2.88% 2.69% 3.24% 2.86% 2.81% 2.29% 1.88% 1.82% 1.18% 1.20%
Long-Term Debt to Total Capital
2.05% 3.23% 2.75% 3.76% 2.90% 2.08% 1.48% 1.02% 21.07% 18.97% 13.96%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
95.64% 93.89% 94.56% 93.00% 94.24% 95.11% 96.23% 97.10% 77.11% 79.85% 84.84%
Debt to EBITDA
-0.11 -0.19 -0.21 -0.39 -0.62 -1.51 1.74 0.39 3.19 2.04 1.26
Net Debt to EBITDA
0.72 0.72 1.00 1.28 2.60 7.97 -12.87 -3.93 0.84 0.36 -0.12
Long-Term Debt to EBITDA
-0.05 -0.10 -0.11 -0.21 -0.31 -0.64 0.68 0.14 2.94 1.92 1.16
Debt to NOPAT
-0.12 -0.20 -0.21 -0.34 -0.40 -0.49 -0.64 -1.57 -21.62 37.80 1.40
Net Debt to NOPAT
0.80 0.76 0.98 1.12 1.67 2.60 4.71 15.96 -5.67 6.63 -0.14
Long-Term Debt to NOPAT
-0.06 -0.11 -0.11 -0.18 -0.20 -0.21 -0.25 -0.55 -19.90 35.59 1.29
Altman Z-Score
5.32 4.11 5.91 3.48 6.45 6.00 7.38 6.78 0.68 0.41 0.74
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.78 1.76 1.77 1.74 1.78 1.95 2.12 2.44 1.53 1.76 1.76
Quick Ratio
1.38 1.35 1.40 1.40 1.38 1.50 1.67 1.97 0.53 0.59 0.62
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-77 -76 -62 -27 -27 -18 -28 -28 -171 -165 -149
Operating Cash Flow to CapEx
-39.14% -13.24% 149.41% 138.33% 230.32% 200.89% 285.18% 232.03% 655.29% 316.85% 406.93%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -71.21 -86.44
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.33 10.60
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.07 8.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.96 1.03 1.11 1.08 1.11 1.13 1.17 1.16 0.91 0.93 0.96
Accounts Receivable Turnover
6.13 6.27 6.77 6.29 6.06 6.15 6.51 5.80 5.62 6.02 6.11
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
18.47 0.00 0.00 17.66 20.70 19.06 20.57 19.68 0.00 0.00 0.00
Accounts Payable Turnover
12.84 17.78 17.36 9.95 19.14 28.11 21.30 13.34 8.35 9.59 7.92
Days Sales Outstanding (DSO)
59.55 58.21 53.91 58.04 60.20 59.37 56.05 62.91 64.96 60.65 59.75
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
28.43 20.52 21.02 36.70 19.07 12.98 17.14 27.37 43.73 38.06 46.11
Cash Conversion Cycle (CCC)
31.12 37.69 32.88 21.34 41.13 46.38 38.92 35.54 21.24 22.60 13.64
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
175 190 184 192 197 206 211 224 363 375 365
Invested Capital Turnover
2.42 2.36 2.45 2.21 2.26 2.20 2.27 2.23 1.72 1.71 1.76
Increase / (Decrease) in Invested Capital
56 62 49 17 21 16 27 32 167 169 154
Enterprise Value (EV)
1,342 1,106 1,365 994 1,586 1,391 1,518 1,260 836 576 657
Market Capitalization
1,418 1,169 1,432 1,057 1,654 1,467 1,604 1,356 810 560 663
Book Value per Share
$4.52 $4.48 $4.38 $4.41 $4.56 $4.80 $5.01 $5.35 $5.59 $5.91 $6.02
Tangible Book Value per Share
$1.76 $1.74 $1.67 $1.70 $1.86 $2.14 $2.38 $2.75 $0.55 $0.95 $2.04
Total Capital
263 269 266 274 281 297 310 330 437 450 438
Total Debt
11 16 14 19 16 15 12 9.55 100 91 66
Total Long-Term Debt
5.40 8.69 7.30 10 8.15 6.16 4.58 3.35 92 85 61
Net Debt
-76 -63 -67 -63 -68 -76 -87 -97 26 16 -6.50
Capital Expenditures (CapEx)
7.86 5.45 7.40 4.18 7.06 7.39 5.20 6.67 5.14 7.55 4.50
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4.10 11 4.29 7.50 13 22 26 42 31 46 42
Debt-free Net Working Capital (DFNWC)
92 90 86 89 97 113 125 148 105 120 115
Net Working Capital (NWC)
86 83 79 80 89 105 118 142 97 115 110
Net Nonoperating Expense (NNE)
9.94 6.13 5.96 4.71 1.06 1.61 -1.71 -1.16 -5.18 1.27 2.59
Net Nonoperating Obligations (NNO)
-76 -63 -67 -63 -68 -76 -87 -97 26 16 -6.50
Total Depreciation and Amortization (D&A)
8.52 6.93 7.55 8.47 6.99 7.05 7.71 7.65 13 11 10
Debt-free, Cash-free Net Working Capital to Revenue
1.15% 2.90% 1.10% 1.85% 3.12% 5.10% 5.86% 9.06% 6.40% 9.23% 8.27%
Debt-free Net Working Capital to Revenue
25.71% 24.18% 22.08% 22.03% 23.18% 26.01% 27.71% 32.02% 21.76% 24.31% 22.64%
Net Working Capital to Revenue
24.01% 22.11% 20.24% 19.84% 21.26% 24.09% 26.13% 30.68% 20.10% 23.24% 21.60%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Adjusted Weighted Average Basic Shares Outstanding
54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 59.59M 60.01M 59.74M 60.94M 61.88M
Adjusted Diluted Earnings per Share
($0.55) ($0.35) ($0.31) ($0.25) ($0.11) ($0.07) $0.01 $0.07 $0.03 $0.05 $0.03
Adjusted Weighted Average Diluted Shares Outstanding
54.56M 56.67M 57.50M 57.89M 57.59M 58.92M 61.69M 61.56M 61.49M 62.04M 62.46M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
56.39M 57.40M 57.77M 58.12M 58.77M 59.50M 59.91M 60.29M 60.76M 61.81M 62.07M
Normalized Net Operating Profit after Tax (NOPAT)
-21 -14 -12 -9.69 -5.33 -2.30 -1.05 3.12 -3.89 4.23 4.51
Normalized NOPAT Margin
-21.79% -13.43% -11.81% -9.07% -4.86% -1.98% -0.90% 2.59% -3.06% 3.23% 3.48%
Pre Tax Income Margin
-32.03% -18.98% -16.90% -13.07% -4.90% -2.74% -0.48% 4.26% -8.12% 3.61% 2.50%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.91 2.73
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.83 2.61
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.35 0.12
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.43 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Phreesia’s latest quarter shows a business that is still growing revenue, generating positive operating cash flow, and gradually improving profitability, but the quarter also highlights heavier spending and a more leveraged balance sheet than a year ago.

For Q1 fiscal 2027, revenue rose to $130.9 million, up from $127.1 million in the prior quarter and $115.9 million in the same quarter last year. Gross profit also expanded to $113.3 million, keeping gross margin strong at roughly 86%. However, operating expenses remained high at $106.5 million, leaving the company with just $6.7 million in operating income and $3.0 million in net income.

Cash generation was a clear strength in the quarter. Phreesia produced $23.9 million of operating cash flow, and even after $7.6 million of capital spending, it still posted a positive $2.6 million increase in cash and equivalents. That said, the company used meaningful financing cash flows to manage debt, including $116.2 million of debt repayment offset by $92.2 million of new debt issuance.

The balance sheet remains sizable, with $666.1 million in assets, $307.1 million in liabilities, and $359.1 million in equity at quarter-end. Cash and restricted cash totaled $74.7 million, while total debt stood at about $90.6 million combined short-term and long-term. Compared with one year ago, debt appears lower and cash is still healthy, but liabilities remain substantial.

Key takeaways for investors:

  • Revenue continues to trend higher, with Q1 2027 sales up year over year and sequentially.
  • Gross profit remains strong, suggesting Phreesia still has attractive unit economics at the top line.
  • Operating cash flow was solid at $23.9 million, showing the business can still convert earnings into cash.
  • The company ended the quarter with positive cash growth, despite ongoing investment spending.
  • Debt declined versus prior periods at least on a net basis, helped by large repayments.
  • Operating margins are still thin, so revenue growth has not yet translated into strong operating leverage.
  • Capital spending remains steady, which supports the platform but limits free cash flow.
  • Phreesia is still spending heavily on marketing and R&D, which may support growth but also pressures earnings.
  • Net income is positive but small relative to revenue, leaving little cushion if growth slows.
  • Interest expense and debt management remain important given the company’s leverage and refinancing activity.
  • Balance sheet liabilities are still meaningful, especially current liabilities, which investors should monitor closely.

Looking at the broader four-year trend, Phreesia has made meaningful progress. In early 2023 and 2024, the company was producing large quarterly losses and negative operating cash flow. Over the last several quarters, revenue has continued to rise, operating cash flow has improved, and the company has moved closer to consistent profitability. The main question now is whether Phreesia can keep scaling revenue fast enough to absorb its still-elevated expense base.

Bottom line: Phreesia looks financially healthier than it did a year or two ago, with better revenue growth, stronger cash generation, and improving earnings. But the stock still depends on the company proving it can turn that growth into durable profitability while keeping leverage under control.

09/12/26 06:32 PM ETAI Generated. May Contain Errors.

Phreesia Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Phreesia's financial year ends in January. Their financial year 2026 ended on January 31, 2026.

Phreesia's net income appears to be on an upward trend, with a most recent value of $2.31 million in 2026, falling from -$18.19 million in 2018. The previous period was -$58.53 million in 2025. View Phreesia's forecast to see where analysts expect Phreesia to go next.

Phreesia's total operating income in 2026 was -$6.61 million, based on the following breakdown:
  • Total Gross Profit: $409.23 million
  • Total Operating Expenses: $415.84 million

Over the last 8 years, Phreesia's total revenue changed from $79.83 million in 2018 to $480.59 million in 2026, a change of 502.0%.

Phreesia's total liabilities were at $326.58 million at the end of 2026, a 164.2% increase from 2025, and a 412.3% increase since 2019.

Over the last 8 years, Phreesia's book value per share changed from 0.00 in 2018 to 5.59 in 2026, a change of 559.3%.



Financial statements for NYSE:PHR last updated on 9/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners